In patients with NAFLD or NASH, we found that Trim31 levels were drastically reduced, but hepatic Rhbdf2 levels were increased, compared to the levels in non-steatosis samples. Here, RHBDF2 is linked to metabolic dysfunction-associated steatohepatitis.